Baird Initiates Coverage On Medtronic with Neutral Rating, Announces Price Target of $90
Portfolio Pulse from richadhand@benzinga.com
Baird analyst David Rescott has initiated coverage on Medtronic (NYSE:MDT) with a Neutral rating and a price target of $90.
July 19, 2023 | 8:55 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Medtronic has been given a Neutral rating by Baird with a price target of $90.
The Neutral rating from Baird indicates that the analyst believes Medtronic's stock is fairly valued at current levels. The price target of $90 suggests that the analyst sees limited upside potential in the short term. This could lead to a neutral or slightly negative reaction in the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100